Related Experiment Video
Updated: Apr 17, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic Delivery
Jeannine M Coburn1, David L Kaplan1
1†Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.
Abstract:
The standard of care for cancer patients includes surgical resection, radiation, and chemotherapy with cytotoxic chemotherapy drugs usually part of the treatment. However, these drugs are commonly associated with cardiotoxicity, ototoxicity, nephrotoxicity, peripheral neuropathy, and myelosuppression. Strategies to deliver cytotoxic chemotherapy drugs while reducing secondary toxicity and increasing tumor dosing would therefore be desirable. This goal can be achieved through the use of controlled release drug carrier systems. The aim of this review is to provide an overview of clinically used drug carrier systems and recently developed approaches for drug-biomaterial conjugation.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Stimuli-Activated
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Distribution: Tissue Binding
For...

